Article
Developing High-Yield and Safe Therapeutic EVs by Ablating Tissue Factor-Mediated Toxicity
2025-12-25
Abstract excerpt
The clinical translation of extracellular vesicles (EVs) as next-generation drug delivery vehicles is currently stalled by two interrelated challenges: the difficulty of manufacturing EVs at an industrial scale ("the yield problem") and the risks of toxicity associated with systemic administration of high doses ("the safety ceiling"). In this comprehensive study, we present a two-pronged genetic engineering strate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d0d5123c-52a2-5aac-b472-f80830db1238
- DOI
- 10.64898/2025.12.25.696171
